Target intelligence / Profile preview

Angiopoietin-like protein 3 (ANGPTL3)

Target
ANGPTL3
Molecular classification
Angiopoietin-like proteins
01

Overview

Angiopoietin-like protein 3 (ANGPTL3) is a secreted glycoprotein primarily expressed in the liver and plays a central role in lipid metabolism, angiogenesis, and disease states related to lipid disorders. It inhibits lipoprotein lipase (LPL) and endothelial lipase (EL), leading to increased plasma levels of triglycerides and affecting HDL metabolism. Inhibition of ANGPTL3 is a therapeutic target for dyslipidemias.

Other names
ANGPTL3
02

Mechanism of action

Inhibition of ANGPTL3 reduces plasma LDL cholesterol and triglycerides.

03

Biological functions

Regulation of lipid metabolismInhibition of lipoprotein lipase (LPL)Inhibition of endothelial lipase (EL)Promotion of angiogenesisStem cell expansionInflammation modulationTissue remodeling
04

Disease associations

Familial combined hypolipidemiaDyslipidemiaCardiovascular diseaseCancer
05

Safety considerations

Potential impact on angiogenesisLong-term effects of ANGPTL3 inhibition are still being studied
06

Interacting drugs

Monoclonal antibodies targeting ANGPTL3

1 more in the full profile.

07

Biomarkers

Plasma levels of ANGPTL3LDL-C levelsHDL-C levelsTriglyceride levels

Beyond the preview

Go deeper on Angiopoietin-like protein 3 (ANGPTL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiopoietin-like protein 3 (ANGPTL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call